streptomycin, and the Schu $5 strain, resistant to streptomycin, were highly virulent for mice, guinea pigs, and rabbits. 1 organism constituted 1 I~50 for mice for both of these strains by either subcutaneous or intraperitoneal injection. The challenge strains were maintained in a lyophilized state. Working stock suspensions were grown first on SB agar and then in a modified casein hydrolysate medium similar to that described by Mills et al. (8) . Fresh stock suspensions were prepared every 4 to 5 weeks and held at 4 to 6°C. Dilutions for challenge were made in sterile gelatin saline, containing 0.9 per cent sodium chloride and 0.1 per cent gelatin. Virulence of these challenge strains was checked periodically in rabbits. They were considered fully virulent if more than 50 per cent of the rabbits died of tularemia within 10 days following subcutaneous injection of 5 to 10 organisms.
The EV-76 strain of Pasteurella pestis, grown on slants of blood agar base (Difco) at 21°C for 24 hours, was maintained on this medium at 4 to 6°C.
Immunization of Donor Mice.--Mice 8 weeks or more old were immunized by infection with P. tularemis, strain yap. Primary immunization consisted of approximately 5 X 1@ organisms injected by the intraperitoneal route. A booster dose of approximately 5 X 107 organisms was injected by the intraperltoneal route 4 to 5 weeks after the primary dose. These mice are hereafter referred to as immune mice and their tissues as immune tissues.
Mice were immunized with a killed tularemia vaccine by intraperitoneai injection on 5
successive days of 0.5 ml doses of a suspension of acetone-killed P. tularensis strain Schu $5, at a concentration of 4 X 10 ~° cells per ml. 14 days after the initial series the mice were similarly injected with a single booster dose of this vaccine.
Mice were immunized with P. pestis strain EV-76 by a subcutaneous injection of approximately 1 X 107 viable organisms and 28 days later received 1 X 108 viable organisms by the intraperitoneal route.
Harvest and Transfer of Tissues.--Peritoneal leucocytes were obtained from immunized or normal donor mice 4 to 6 days after an intraperitoneal injection of 1 ml of 0.9 per cent saline. Immunized donors received a booster injection of vaccine 2 to 4 days before the saline injection. The mice were anesthetized by subcutaneous injections of sodium pentobarbital, exsanguinated by cardiac puncture, and the peritoneal cavities injected with 8 ml of Hanks's balanced salt solution (BSS). The abdomens were kneaded gently and the suspended cells were withdrawn by a syringe and needle. Leucocytes were counted, centrifuged at 500 g for 5 minutes, and resuspended in fresh, cold BSS to the desired concentration. Recipients were injected intraperitoneally with 1 ml of the leucocyte suspension within 6 hours after harvest. For the passive transfer of spleen tissue or other reticuloendothelial (RES) tissue, donor mice were anesthetized, exsanguinated, and the organs excised. The organs were immediately washed in cold BSS, placed in shallow dishes containing BSS plus 10 per cent horse or bovine serum, and minced and teased apart with surgical scalpels. Crushing of tissues was carefully avoided. Large pieces of debris were removed by filtering the suspension through a 200 mesh stainless steel wire sieve. The resulting filtrate contained individually suspended cells and aggregates of up to 20 cells per clump. Total cells and leucocytes were counted, centrifuged at 500 g for 5 to 10 minutes, and resuspended in cold BSS to the desired concentration. Recipient mice, 6 to 8 weeks old, were injected intraperitoneally with 1 ml of the tissue suspension.
Viability of the tissues was determined at the time of transfer by suspending cells in 0.9 per cent saline containing 1 per cent trypan blue and immediately counting the percentage of colorless, and hence viable, cells.
Measurement of Resistance to
Tularemia.--Mice were challenged intraperitoneally or subcutaneously with _P. tularensis and observed for deaths daily for 28 days. Death times and survivors were appropriately combined into a single value, the mean reciprocal death time (MRDT), in a manner similar to that used by Brownlee and Hamre (9) . Tile MRDT and standard deviation were calculated for each challenged group. For example, death times of 6, 7, 8, 8, 8, 8, 9 , 9 days and 2 survivors for a group of 10 mice would have an MRDT equal to ~'6 + ~d: + ~'~ + ~'6 + 2/i, or 0.103. The longer the animals survived, the smaller was 10 the MRDT. It was assumed from previous experience that mice surviving 28 days after challenge would have a death time of infinity for these experiments. Differences in resistance between 2 groups of animals, as measured by MRDT's, were tested for significance by the t test (10 tularensis strain Schu $4. Groups of untreated mice and immune mice were challenged similarly.
Examination of stained preparations of the peritoneal leucocytes revealed lymphocytes and monocytes in approximately equal numbers, and less than 1 per cent of other leucocyte types. No significant differences in cell type or in cellular morphology were observed between leucocytes from normal and from immune donors.
The ratios of deaths to total numbers of mice challenged are presented in Table I along with mean reciprocal death times (MRDT) and their standard deviations (s.D.). Using the t statistic and a probability of error of 0.05, it was determined that recipients of immune peritoneal leucocytes were significantly more resistant to tularemia than all other groups of recipient mice and untreated mice, but were obviously less resistant than immune donor mice. Recipients of 0.33 ml of immune serum only were not significantly more resistant than recipients of normal serum and normal cells, but were significantly more resistant than previously untreated mice. In additional experiments this slight resistance of animals inoculated with immune serum was not increased appreciably when the volume of antiserum was increased to 1.0 ml. No animal that received immune serum alone survived challenge.
Three of 30 recipients of immune leucocytes survived challenge, and these animals were rechallenged in the same manner after 6 weeks. All animals died at the same rate as the normal mice, indicating that infection had been absent or minimal following the initial challenge, since no active immunity developed. The initial passive immunity was evidently of relatively short duration in these non-inbred mice. Previous experience had indicated that active immunity in mice persisted at least 3 months after recovery from infection with the Jap strain of P. tularensis.
Consideration was given to the possibility that the enhanced resistance of recipient mice resulted from infection with organisms present in the leucocyte suspension. However, no colonies of P. tularensis were cultivated by incubation of the immune leucocyte suspension on SB agar plates, and normal mice failed to show a significant resistance to tularemia 24 hours after intraperitoneal injection of viable Jap strain organisms. For these reasons the observed resistance was believed to be caused by factors other than an active immunity. 
Transfer of Cells from Spleens and Other Organs.--When it was shown that
transfer of immune peritoneal leucocytes could enhance the resistance of recipients, other tissues of the reticuloendothelial system (RES) of immune mice were investigated in a similar manner. These tissues included spleen, liver, mesenteric lymph nodes, lung, and sternal bone marrow. Resistance to tularemia was increased among recipients of immune spleen tissue and to a lesser degree among recipients of lymph node tissue. No increase in resistance was observed among recipients of other transferred tissues. The passively acquired resistance of recipients of immune spleen cells equalled and often exceeded the previously described resistance of recipients of immune peritoneal leucocytes. High concentrations of cells were readily obtained from spleen tissue, and accordingly spleen cells were used in subsequent experiments.
Spleens removed from immune donors between 5 and 12 days after a booster dose of live vaccine were usually 2 to 3 times the size of normal spleens. Thereafter the size of the spleen returned to normal. The ability of suspensions of spleen tissue to transfer resistance to tularemia appeared to be maximal during this interval of splenomegaly. In evaluating the resistance observed in recipient mice consideration was given again to the possibility of active immunity developing as a result of simultaneous transfer of intracellular, viable P. tularensis. This possibility was apparently eliminated by suspending the spleen cells in BSS containing 100 #g of dihydrostreptomycin and 10 units of penicillin per ml, the latter included to control other contaminants. After the cells were treated with antibiotics and washed, no viable P. tularensis was recovered by plating, although viable organisms were usually present initially. As a further precaution against infection, recipients were treated with 400 #g of streptomycin per day by subcutaneous injection until 24 hours before challenge, but for no longer than 12 days following transfer of tissues. All other challenge groups were similarly treated unless otherwise stated. The streptomycin-resistant Schu $5 strain was used for challenge to avoid possible effects of residual streptomycin.
The experimental data presented in Table II are typical of results obtained after challenge of recipients of passively transferred spleen tissue. No significant difference was observed between the resistances of recipients of normal spleen cells with normal serum and untreated mice. By subcutaneous challenge, no significant difference was observed between the resistance of recipients of immune spleen cells and recipients of immune sera, although a decided difference in resistance between these groups was observed if challenge was by the intraperitoneal route. These results were confirmed in replicate experiments.
TABLE III Passively Transferred Graded Doses of Immune Spleen Cells and Killed Immune Spleen Cells
Number of spleen cells transferred Dead/Tested MRDT (=ks.I).)* Cells killed by heating at 56°C for 30 minutes. Table III . Resistance appeared to be directly proportional to the log10 number of viable, immune spleen cells transferred. Extrapolation of these data suggests that transfer of 1 billion or more spleen cells would allow essentially complete survival of recipients after intraperitoneal challenge. Transfer of such large numbers of cells was not technically feasible. In order to protect a small percentage of recipients completely and consistently against challenge, however, 10 s or more spleen cells from immune donors were required, and in several experiments the survivors in such groups ranged from 10 to 70 per cent.
Recipients of viable immune spleen cells

Effect of Graded Doses of Immune Spleen Cells.--The degree of resistance resulting in recipient A/LN mice after the passive transfer of graded doses of spleen cells from immune isologous donors is presented in
Data presented in Table III also indicate that transfer of killed immune spleen cells did not increase the resistance of recipients. In other experiments immune spleen cells that were killed by crushing or by repeated freezing and thawing were also inactive. It would appear that the immunity transmitted by phagocytic cells was associated with only viable tissues, and hence is not a result of humoral antibody.
The duration of passively acquired resistance to tularemia was investigated in inbred, A/LN strain recipients by challenging 1, 3, 7, and 21 days following the passive transfer of 1.1 X 108 immune spleen cells. Homologous Fort Detrick strain recipients were compared with isologous A/LN strain recipients at 2 of the 4 intervals. Untreated mice of these 2 strains were previously determined to be equally susceptible to similar doses of P. tularensis administered subcutaneously or intraperitoneally. The results presented in Table IV the same at the 4 intervals tested. All of the Fort Detrick strain of recipients succumbed to tularemia after challenges at 3 and 21 days post-transfer. Using the MRDT as a measure of resistance, it appeared that by 21 days post-transfer, the non-inbred recipients lost nearly all of the resistance demonstrated at 3 days post-transfer. No such sharp decrease was noted in the resistance of inbred recipients over the same time period. This difference in resistance between isologous and homologous recipients suggests that a tissue transplantation immunity or homograft reaction developed in non-inbred recipients. Such a phenomenon could cause early rejection of transferred viable tissues from genotypically heterologous mice (12) and thereby reduce the efficiency of the resistance mechanism associated with the transferred cells. Proof of this must await further experimentation.
Transfer of Tissues from Donors Immunized with Other
Vaccines.--The transfer of isologous spleen cells from mice immunized with either non-viable P. tularensis or with viable P. pestis vaccines served as controls for the immuniza-tion techniques used in the previous experiments. Donors, recipients, and previously untreated mice were challenged intraperitoneally with the Schu $5 strain on the 3rd day post-transfer. Resistance was no greater among mice immunized with viable P. pestis and recipients of spleen tissue and/or serum from these animals than it was among untreated mice and, hence, need not be described here in detail. As expected, all mice succumbed to tularemia following challenge. Only those mice immunized with the non-viable P. tularensis vaccine and recipients of serum from donors similarly immunized died significantly later than previously untreated controls (Table V) . These results suggest that passive transfer of cellular immunity to tularemia was possible only if donors were specifically immunized by infection with P. tularensis. 
DISCUSSION
The data indicate clearly that immunity to fully virulent strains of P. tularensis can in fact be transferred to normal animals by tissues from an immune donor. The following results appear to eliminate the possibility that this immunity was a result of active immunization by the simultaneous transfer of viable P. tularensis or its antigens: (a) no viable P. tularensis were recovered from antibiotic-treated donor cells, (b) resistance was transferred with viable spleen cells but not with cells inactivated by freezing and thawing, a procedure that is not especially detrimental to P. tularensis, and (c) resistance did not persist in non-inbred recipients as long as in isologous recipients.
A significant percentage of recipients of immune cells survived intraperitoneal challenge and as a group were considerably more resistant than recipients of immune sera. Following subcutaneous challenge, however, all recipients of immune cells died and were no more resistant than similarly challenged recip-ients of immune sera. These results might be explained by postulating that the transferred immune cells tended to remain in the peritoneal cavity or its efferent lymphatics. Under these conditions the immune cells would be effective against intraperitoneally injected organisms, but not against challenge at a remote site such as the skin.
In all cases in which a considerable degree of immunity was transferred by means of spleen cells, splenomegaly was observed in donor mice. Because this splenic hyperplasia was evident in the gross only in mice immunized with infectious P. tularensis it was inferred that, in part, this condition represented the host's response to tularemia and was possibly associated with the proliferation of immune cells. As the splenomegaly subsided, these cells may have disseminated throughout the host, thereby reducing the ratio of immune to normal cells in this organ. The resistance of immune donor mice was invariably greater than that of recipients of their spleen cells. A certain loss of efficiency would be expected for cells that had been removed by mincing an intact organ such as the spleen and dispersed into an alien environment such as the peritoneal cavity of another host. This disadvantage appeared to be partially overcome by transferring large numbers of immune cells. In fact, the resistance of the recipients was proportional to the number of immune cells transferred.
Other reticuloendothelial tissue of immune mice besides spleen and peritoneal leucocytes might also contain immune cells but not in sufficient numbers to be detectable by the technique used here. It would be unnecessary, however, to postulate that all tissues of mice become immune following a tularemia infection. The action of serum antibody would tend to localize the infectious agent in the sinuses of RES organs where they would be destroyed or rendered innocuous by fixed or migrating immune phagocytic cells.
Tularemia in mice has definite advantages as a model for study of cellular immunity. Brucellosis and tuberculosis, frequently used in such studies, are chronic or sublethal in most hosts unless infection is initiated with massive numbers of organisms. In the case of tularemia, however, rapidly progressive and uniformly fatal infections may be initiated in normal mice with small numbers of organisms. Antibiotic-resistant and antibiotic-susceptible strains of P. tularensis of graded virulence are available, and laboratory personnel may be safely and effectively immunized through the use of a recently developed viable vaccine (13, 14) .
SUMMARY
Acquired resistance to fully virulent strains of P. tularensis was passively transferred to normal mice by viable spleen cells or peritoneal leucocytes from donors that recovered from infection with an attenuated strain of P. tularensis. This passively transferred resistance was reflected in survival or delayed death after challenge of the recipients. The degree of passively transferred resistance was dependent upon the immune status of the donors and the number of viable immune cells transferred. There were indications that this resistance persisted only as long as the transferred tissues were compatible with the tissues of the recipient. The results support the hypothesis that immunity of mice against fully virulent strains of P. tularensis is associated with an altered state of the tissues.
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